Science and Engineering Ethics 11 (1) (2005)
|Abstract||This paper offers a few elements of an answer to the question to what extent drug patents can be morally justified. Justifications based on natural rights, distributive justice and utilitarian arguments are discussed and criticized. The author recognizes the potential of the patents to benefit society but argues that the system is currently evolving in the wrong direction, particularly in the field of drugs. More than a third of the world’s population has no access to essential drugs. The working of the patent system is an important determinant of access to drugs. This paper argues that drug patents are not easily justified and that the ‘architecture’ of the patent system should be rethought in view of its mission of benefiting society.|
|Keywords||No keywords specified (fix it)|
|Through your library||Configure|
Similar books and articles
Miriam Bentwich (2012). It's About Scientific Secrecy, Dummy: A Better Equilibrium Among Genomics Patenting, Scientific Research and Health Care. Science and Engineering Ethics 18 (2):263-284.
Michael Huemer (2004). America's Unjust Drug War. In Bill Masters (ed.), The New Prohibition. Accurate Press.
Sigrid Sterckx (2004). Patents and Access to Drugs in Developing Countries: An Ethical Analysis. Developing World Bioethics 4 (1):58–75.
Sivaramjani Thambisetty & Kartik Kumaramangalam, Peer-Review and Patents: Why the Goose That Lays the Golden Egg is a Red Herring.
Tadeusz Tołłoczko (2005). Surgical Patents and Patients — the Ethical Dilemmas. Science and Engineering Ethics 11 (1).
James Wilson (2007). GM Crops: Patently Wrong? Journal of Agricultural and Environmental Ethics 20 (3).
Added to index2009-01-28
Total downloads14 ( #83,010 of 548,984 )
Recent downloads (6 months)1 ( #63,327 of 548,984 )
How can I increase my downloads?